Home / Resource Library / Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphomaPortuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma Real world study of ibrutinib for treatment of MCL.